Orthofix Medical Inc.

Equities

OFIX

US68752M1080

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 09:32:46 2024-05-17 am EDT			5-day change	1st Jan Change
14.96 ^USD	-0.99%		+4.28%	+12.09%

May. 09	Orthofix Medical Inc. Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail	CI
May. 08	Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target	MT

Engine Capital Management Engages in Discussions with Orthofix Medical

November 03, 2023 at 05:15 pm EDT

On November 3, 2023, Engine Capital Management, LP announced that it has engaged, and expects to continue to engage, in discussions with Orthofix Medical Inc.?s Board of Directors regarding certain governance matters.

Latest news about Orthofix Medical Inc.

Orthofix Medical Inc. Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail	May. 09	CI
Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target	May. 08	MT
Transcript : Orthofix Medical Inc., Q1 2024 Earnings Call, May 07, 2024	May. 07
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q1 Revenue $188.6M	May. 07	MT
Orthofix Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Orthofix Medical Inc. Revises Earnings Guidance for the Year 2024	May. 07	CI
Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer	Apr. 16	CI
Orthofix Medical Inc. Announces Board Resignation	Apr. 12	CI
Orthofix Medical Inc. Appoints Lucas Vitale as Chief People and Business Operations Officer	Mar. 18	CI
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set	Mar. 05	MT
Orthofix Medical Inc. Provides Revenue Guidance for the First Quarter, Second Quarter and Third Quarter of 2024	Mar. 05	CI
Transcript : Orthofix Medical Inc., Q4 2023 Earnings Call, Mar 05, 2024	Mar. 05
Orthofix Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q4 Revenue $200.4M, vs. Street Est of $195.6M	Mar. 05	MT
Orthofix Medical Guides For 2024 Sales of $785-$795 Million, vs CIQ Analyst Consensus of $799 Million	Mar. 05	MT
Orthofix Medical Inc. Provides Earnings Guidance for the Year 2024	Mar. 05	CI
Orthofix Medical Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 05	CI
Orthofixan Signs Deal to Distribute BoneMRI Imaging Software in US	Jan. 18	MT
Orthofix Announces Commercial Partnership with MRIguidance	Jan. 18	CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Posts Q4 Revenue $200.3M	Jan. 09	MT
Orthofix Medical Inc. Names Massimo Calafiore as President and Member of the Board of Directors Effective Immediately	Jan. 08	CI
Orthofix Medical Inc. Names Massimo Calafiore as Chief Executive Officer	Jan. 08	CI
Orthofix Medical Inc. Appoints Julie Andrews as Chief Financial Officer	Jan. 08	CI
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis	Dec. 21	CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 1000	Dec. 18	CI

Chart Orthofix Medical Inc.

Duration

Period

More charts

Company Profile

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-18 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Orthofix Medical Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

15.11 USD

Average target price

20.13 USD

Spread / Average Target

+33.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ORTHOFIX MEDICAL INC.	+12.09%	567M
ABBOTT LABORATORIES	-4.72%	182B
MEDTRONIC PLC	+3.96%	114B
BECTON, DICKINSON AND COMPANY	-2.93%	68.38B
DEXCOM, INC.	+6.30%	52.46B
CENCORA, INC.	+8.02%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+26.18%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	+0.57%	25.79B

Other Medical Equipment, Supplies & Distribution